Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Ipsen Buys Into BAX Inhibitor, Targeting Certain Cancers
Ipsen And BAKX Will Develop Latter’s BCL-2 Inhibitor
Jul 28 2021
•
By
Sten Stovall
Investigational BKX-001 is an oral small-molecule activator of BAX • Source: Alamy
More from Clinical Trials
More from R&D